| payload |
{"created_at":"2026-04-09T22:59:43.472 {"created_at":"2026-04-09T22:59:43.472613+00:00","dedupe_key":"signal_enriched:discovery_ipo_delta:1fcdab4c7c277295","evidence_event_ids":["evt_afd6ddb77a86"],"signal_type":"discovery_ipo_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNT0ZsbUNFeWRINFJFWGVIM3dGTVh0cW9vZkY2TE5IU2FQV3pBaW12SktQSzlWZGhSUklwOUIxYkhjaE1YVnAwdjdraTZ5RDJxQnVwZVRTdWozSFpUNURaWVBFQ3VQNjVJNWFIeFJwWXlXTUkzdnNaeVFxY0dTcTRfcU9LS3NzbHZKWFJHb2FqdllVcWFDNTF6dldsUjVEbzlSZm1R?oc=5","as_of":"2026-04-09T22:59:43.472613+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNT0ZsbUNFeWRINFJFWGVIM3dGTVh0cW9vZkY2TE5IU2FQV3pBaW12SktQSzlWZGhSUklwOUIxYkhjaE1YVnAwdjdraTZ5RDJxQnVwZVRTdWozSFpUNURaWVBFQ3VQNjVJNWFIeFJwWXlXTUkzdnNaeVFxY0dTcTRfcU9LS3NzbHZKWFJHb2FqdllVcWFDNTF6dldsUjVEbzlSZm1R?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_294607a221d74ffe","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-10T02:48:44.451771+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNT0ZsbUNFeWRINFJFWGVIM3dGTVh0cW9vZkY2TE5IU2FQV3pBaW12SktQSzlWZGhSUklwOUIxYkhjaE1YVnAwdjdraTZ5RDJxQnVwZVRTdWozSFpUNURaWVBFQ3VQNjVJNWFIeFJwWXlXTUkzdnNaeVFxY0dTcTRfcU9LS3NzbHZKWFJHb2FqdllVcWFDNTF6dldsUjVEbzlSZm1R?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"gstatic.com","publisher_resolution":"canonical_aggregator_unresolved","requested_url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNT0ZsbUNFeWRINFJFWGVIM3dGTVh0cW9vZkY2TE5IU2FQV3pBaW12SktQSzlWZGhSUklwOUIxYkhjaE1YVnAwdjdraTZ5RDJxQnVwZVRTdWozSFpUNURaWVBFQ3VQNjVJNWFIeFJwWXlXTUkzdnNaeVFxY0dTcTRfcU9LS3NzbHZKWFJHb2FqdllVcWFDNTF6dldsUjVEbzlSZm1R?oc=5","source_event_id":"evt_afd6ddb77a86","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"8b2e6269bae88051","kind":"ipo_calendar","published_at":"2026-04-09T21:31:00+00:00","publisher_domain":"gstatic.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.55,"dates_mentioned":[],"entities":[{"asset_class":"equity","name":"Avalyn Pharma","relevance":"primary","symbol":"","type":"company"}],"event_type":"listing","information_gaps":["The provided cleaned article text contains only CSS/HTML styling and does not include the actual article content.","No IPO date, exchange/ticker symbol, offer price, number of shares, proceeds, valuation, or underwriters are provided in the text.","No details on the specific drug candidate, clinical stage, trial results, or regulatory status are included in the provided content.","No confirmation of whether the company is listed on a specific exchange is present in the provided text."],"key_facts":["Headline states: \u201cAvalyn Pharma IPO: Inhaled Pulmonary Fibrosis Drug Developer Goes Public.\u201d","Source summary repeats the same headline-level claim."],"numeric_claims":[],"primary_claim":"Avalyn Pharma has completed an IPO and is now publicly listed, as described by the IndexBox headline.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"The signal indicates that Avalyn Pharma, a developer of an inhaled pulmonary fibrosis drug, has gone public via an IPO. No additional IPO terms or performance metrics are present in the provided article text.","topics":["IPO","Avalyn Pharma","inhaled pulmonary fibrosis drug development","going public"]},"source":"IndexBox","source_domain":"gstatic.com","summary":"Avalyn Pharma IPO: Inhaled Pulmonary Fibrosis Drug Developer Goes Public - News and Statistics IndexBox","tickers":[],"title":"Avalyn Pharma IPO: Inhaled Pulmonary Fibrosis Drug Developer Goes Public - News and Statistics - IndexBox","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}}... |